158 related articles for article (PubMed ID: 38165364)
1. Muscle MRI in Patients With Oculopharyngeal Muscular Dystrophy: A Longitudinal Study.
Kroon RHMJM; Kalf JG; de Swart BJM; Heskamp L; de Rooy JWJ; van Engelen BGM; Horlings CGC
Neurology; 2024 Jan; 102(1):e207833. PubMed ID: 38165364
[TBL] [Abstract][Full Text] [Related]
2. Muscle ultrasound is a sensitive biomarker in oculopharyngeal muscular dystrophy.
Kroon RHMJM; Kalf JG; Meijers RL; de Swart BJM; Cameron IGM; Doorduin J; van Alfen N; van Engelen BGM; Horlings CGC
Muscle Nerve; 2022 Oct; 66(4):453-461. PubMed ID: 35859342
[TBL] [Abstract][Full Text] [Related]
3. Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD).
Melkus G; Sampaio ML; Smith IC; Rakhra KS; Bourque PR; Breiner A; Zwicker J; Lochmüller H; Brais B; Warman-Chardon J
Neuromuscul Disord; 2023 Jan; 33(1):24-31. PubMed ID: 36462961
[TBL] [Abstract][Full Text] [Related]
4. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the muscle involvement along the disease progression in a large cohort of oculopharyngodistal myopathy compared to oculopharyngeal muscular dystrophy.
Eura N; Noguchi S; Ogasawara M; Kumutpongpanich T; Hayashi S; Nishino I;
J Neurol; 2023 Dec; 270(12):5988-5998. PubMed ID: 37634163
[TBL] [Abstract][Full Text] [Related]
6. Involvement of pelvic girdle and proximal leg muscles in early oculopharyngeal muscular dystrophy.
van der Sluijs BM; Lassche S; Knuiman GJ; Kusters B; Heerschap A; Hopman M; Schreuder TH; van Engelen BGM; Voermans NC
Neuromuscul Disord; 2017 Dec; 27(12):1099-1105. PubMed ID: 29102430
[TBL] [Abstract][Full Text] [Related]
7. Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.
Fischmann A; Gloor M; Fasler S; Haas T; Rodoni Wetzel R; Bieri O; Wetzel S; Heinimann K; Scheffler K; Fischer D
J Neurol; 2011 Jul; 258(7):1333-40. PubMed ID: 21340522
[TBL] [Abstract][Full Text] [Related]
8. Thigh and Leg Muscle MRI Findings in GNE Myopathy.
Fatehi F; Advani S; Okhovat AA; Ziaadini B; Shamshiri H; Nafissi S
J Neuromuscul Dis; 2021; 8(4):735-742. PubMed ID: 34334416
[TBL] [Abstract][Full Text] [Related]
9. Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders.
Keene KR; Notting IC; Verschuuren JJGM; Voermans N; de Keizer ROB; Beenakker JM; Tannemaat MR; Kan HE
J Neuromuscul Dis; 2023; 10(5):869-883. PubMed ID: 37182896
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging and computed tomography of skeletal muscles in oculopharyngeal muscular dystrophy.
King MK; Lee RR; Davis LE
J Clin Neuromuscul Dis; 2005 Mar; 6(3):103-8. PubMed ID: 19078757
[TBL] [Abstract][Full Text] [Related]
11. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy.
Wang LH; Shaw DWW; Faino A; Budech CB; Lewis LM; Statland J; Eichinger K; Tapscott SJ; Tawil RN; Friedman SD
BMC Musculoskelet Disord; 2021 Mar; 22(1):262. PubMed ID: 33691664
[TBL] [Abstract][Full Text] [Related]
13. Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of
Lin HT; Liu X; Zhang W; Liu J; Zuo YH; Xiao JX; Zhu Y; Yuan Y; Wang ZX
Chin Med J (Engl); 2018 Jun; 131(12):1472-1479. PubMed ID: 29893365
[TBL] [Abstract][Full Text] [Related]
14. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
[TBL] [Abstract][Full Text] [Related]
15. Emerging and established biomarkers of oculopharyngeal muscular dystrophy.
Smith IC; Chakraborty S; Bourque PR; Sampaio ML; Melkus G; Lochmüller H; Woulfe J; Parks RJ; Brais B; Warman-Chardon J
Neuromuscul Disord; 2023 Nov; 33(11):824-834. PubMed ID: 37926637
[TBL] [Abstract][Full Text] [Related]
16. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
[TBL] [Abstract][Full Text] [Related]
17. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
[TBL] [Abstract][Full Text] [Related]
18. Quantitative MRI can detect subclinical disease progression in muscular dystrophy.
Fischmann A; Hafner P; Fasler S; Gloor M; Bieri O; Studler U; Fischer D
J Neurol; 2012 Aug; 259(8):1648-54. PubMed ID: 22297459
[TBL] [Abstract][Full Text] [Related]
19. Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.
Heskamp L; van Nimwegen M; Ploegmakers MJ; Bassez G; Deux JF; Cumming SA; Monckton DG; van Engelen BGM; Heerschap A
Neurology; 2019 Jun; 92(24):e2803-e2814. PubMed ID: 31118244
[TBL] [Abstract][Full Text] [Related]
20. A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion.
Takahashi Y; Morimoto N; Nada T; Morimoto M; Eura N; Minami N; Nishino I
J Neuromuscul Dis; 2023; 10(3):459-463. PubMed ID: 36847015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
